| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |